OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P306. A total of 18 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $75,000 | – | 18,550 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 116,224 | $466,000 | 0.25% |
| B. Riley Wealth Advisors, Inc. | 18,550 | $75,000 | 0.02% |
| Creative Planning | 5 | $0 | 0.00% |
| BlackRock Fund Advisors | 877 | $4,000 | 0.00% |
| Allworth Financial LP | 62 | $0 | 0.00% |
| VANGUARD GROUP INC | 102,927 | $412,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 128 | $0 | 0.00% |
| UBS Group AG | 88 | $0 | 0.00% |
| Wealthspire Advisors, L.P. | 128 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,156 | $9,000 | 0.00% |